glp-1 news today september 29 2025 Drugs: Pulse Survey (U.S.) Ozempic GLP-1 Pitfalls and Natural

38, S63S67

Dual-regulating natural products synchronously regulate immune responses and metabolic activities by targeting hub molecules such as mTOR and SIRT1: they synchronously inhibit Tfh cell differentiation and HIF-1-mediated glycolysis, or form anti-inflammatory-metabolic protective synergistic effects by intervening in the TXNIP/NLRP3 inflammatory axis and PINK1/Parkin mitochondrial homeostasis, thereby effectively blocking the vicious cycle of immune activation-metabolic disorder-vascular remodeling

Alavian KN, Beutner G, Lazrove E, Sacchetti S, Park H-A, Licznerski P, et al

GLP-1 medicines like semaglutide and tirzepatide rarely list hair loss as a side effect